bioRxiv · 10.1101/2021.05.29.446269
Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor
Abstract
The glucagon-like peptide-1 (GLP-1) receptor is a validated drug target for metabolic disorders. Ago-allosteric modulators are capable of acting both as agonists on their own and as efficacy enhancers of orthosteric ligands. However, the molecular details of ago-allosterism remain elusive. Here, we report three cryo-electron microscopy structures of GLP-1R bound to (i) compound 2 (an ago-allosteric modulator); (ii) compound 2 and GLP-1; and (iii) compound 2 and LY3502970 (a small molecule agonist), all in complex with heterotrimeric Gs. The structures reveal that compound 2 is covalently bonded to C347 at the cytoplasmic end of TM6 and triggers its outward movement in cooperation with the ECD whose N terminus penetrates into the GLP-1 binding site. This allows compound 2 to execute positive allosteric modulation through enhancement of both agonist binding and G protein coupling. Our findings offer the structural basis of ago-allosterism at GLP-1R and new knowledge to design better therapeutics.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Cong, Z., Chen, L.-N., Ma, H., Zhou, Q., Zou, X., Ye, C., Dai, A., Liu, Q., Huang, W., Sun, X., Wang, X., Xu, P., Zhao, L., Xia, T., Zhong, W., Yang, D., Xu, H. E., Zhang, Y., Wang, M.-W.. 2021-05-29. Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor. https://doi.org/10.1101/2021.05.29.446269
Cite the original work for its findings. Save a collection to share your selection of sources.